Stock Price Targets and Analyst Ratings

→ You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad)

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.65 +5.8%	$21.00 ➝ $22.00	Outperform ➝ Outperform
ABR Arbor Realty Trust	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.41 +4.0%	$13.00	Neutral ➝ Neutral
ACAD ACADIA Pharmaceuticals	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.00 -0.3%	$19.00 ➝ $19.00	Market Perform ➝ Market Perform
ACVA ACV Auctions	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.10 +1.6%	$23.00 ➝ $23.00	Outperform ➝ Outperform
ADNT Adient	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.12 +2.6%	$38.00 ➝ $33.00	Overweight ➝ Overweight
ADNT Adient	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.12 +2.6%	$32.00 ➝ $30.00	Hold ➝ Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADTH AdTheorent	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.21 -0.9%		Buy ➝ Hold
AEE Ameren	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.91 -0.2%	$76.00 ➝ $81.00	Outperform ➝ Outperform
AEIS Advanced Energy Industries	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$100.12 +2.2%	$107.00 ➝ $113.00	Buy ➝ Buy
AEON AEON Biopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.63 -4.1%	$18.00	Buy ➝ Buy
AFG American Financial Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$130.08 +2.1%	$129.00 ➝ $135.00	Neutral ➝ Neutral
ALB Albemarle	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$130.78 +2.1%	$138.00 ➝ $157.00	Outperform ➝ Outperform
ALB Albemarle	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$130.78 +2.1%	$160.00 ➝ $150.00	Sector Outperform ➝ Sector Outperform
ALDX Aldeyra Therapeutics	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.12 -1.0%	$10.00 ➝ $10.00	Outperform ➝ Outperform
ALDX Aldeyra Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.12 -1.0%	$10.00	Buy ➝ Buy
AME AMETEK	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.05 +0.9%	$173.00 ➝ $171.00	Neutral ➝ Neutral
AMP Ameriprise Financial	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$425.01 +1.4%	$440.00 ➝ $460.00	Buy ➝ Buy
AMRX Amneal Pharmaceuticals	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.65 -1.6%	$7.00 ➝ $9.00	Buy ➝ Buy
AMRX Amneal Pharmaceuticals	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.65 -1.6%	$6.25 ➝ $8.00	Buy ➝ Buy
AMZN Amazon.com	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$188.70 +1.3%	$215.00 ➝ $225.00	Buy ➝ Buy
ANF Abercrombie & Fitch	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.44 +0.5%	$103.00 ➝ $112.00	Equal Weight ➝ Equal Weight
APLD Applied Digital	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.28 +8.3%	$8.00 ➝ $6.00	Buy ➝ Buy
ARM ARM	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		106.98 +5.2%	$180.00 ➝ $180.00	Buy ➝ Buy
ASUR Asure Software	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.30 +3.7%	$12.00 ➝ $10.00	Buy ➝ Buy
ATI ATI	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.08 +1.6%	$55.00 ➝ $70.00	Overweight ➝ Overweight
ATMU Atmus Filtration Technologies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.69 +4.4%	$37.00 ➝ $36.00	Overweight ➝ Overweight
AXL American Axle & Manufacturing	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.66 +2.3%	$7.00 ➝ $8.00	Neutral ➝ Neutral
AXL American Axle & Manufacturing	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.66 +2.3%	$7.50 ➝ $8.00	Neutral ➝ Neutral
AXNX Axonics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.59 +0.5%		Hold
BALL Ball	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.90 +0.5%	$71.00 ➝ $72.00	Equal Weight ➝ Equal Weight
BBU Brookfield Business Partners	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.93 +0.2%	$32.00 ➝ $31.00	Outperform
BBU Brookfield Business Partners	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.93 +0.2%	$30.00 ➝ $31.00	Outperform ➝ Outperform
BCPC Balchem	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.32 +1.9%	$167.00 ➝ $170.00	Buy ➝ Buy
BDC Belden	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.71 -0.6%	$100.00	Buy ➝ Buy
BDX Becton, Dickinson and Company	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$236.60 +0.8%	$305.00 ➝ $312.00	Overweight ➝ Overweight
BEP Brookfield Renewable Partners	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.63 +3.3%	$28.00 ➝ $30.00	Outperform
BEP Brookfield Renewable Partners	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.63 +3.3%	$30.00 ➝ $31.00	Sector Outperform ➝ Outperform
BEP Brookfield Renewable Partners	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.63 +3.3%	$30.00 ➝ $32.00	Outperform
BEP Brookfield Renewable Partners	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.63 +3.3%	$29.00 ➝ $31.00	Outperform
BEP Brookfield Renewable Partners	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.63 +3.3%	$28.00 ➝ $30.00	Outperform
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.
BHE Benchmark Electronics	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.07 +4.5%	$31.00 ➝ $40.00	Buy ➝ Buy
BIDU Baidu	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.33 -0.1%	$210.00 ➝ $180.00	Buy ➝ Buy
BILL BILL	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.87 +0.5%	$65.00 ➝ $60.00	Neutral ➝ Neutral
BKNG Booking	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,598.41 +0.6%	$3,950.00	Market Outperform ➝ Market Outperform
BLCO Bausch + Lomb	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.44 +6.2%	$16.00 ➝ $18.00	Equal Weight ➝ Overweight
BMBL Bumble	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.48 +3.4%	$18.00 ➝ $16.00	Overweight ➝ Overweight
BOOM DMC Global	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.20 -3.2%	$27.00 ➝ $24.00	Buy ➝ Buy
BPMC Blueprint Medicines	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$106.25 -0.9%	$121.00 ➝ $168.00	Buy ➝ Buy
BPMC Blueprint Medicines	Upgraded by	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		$106.25 -0.9%	$50.00 ➝ $97.00	Underperform ➝ Market Perform
BRCC BRC	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.02 +4.4%	$8.00 ➝ $8.00	Outperform ➝ Outperform
BSBR Banco Santander (Brasil)	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.88 +0.7%		Neutral ➝ Buy
BTSG BrightSpring Health Services	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.41 -0.8%	$15.00 ➝ $16.00	Overweight ➝ Overweight
BURL Burlington Stores	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$188.02 +1.3%	$233.00 ➝ $218.00	Overweight ➝ Overweight
BWA BorgWarner	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.94 +1.4%	$44.00 ➝ $45.00	Overweight ➝ Overweight
BWA BorgWarner	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.94 +1.4%	$33.00 ➝ $41.00	Neutral ➝ Neutral
BXP Boston Properties	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.56 +1.3%	$73.00 ➝ $69.00	Outperform ➝ Outperform
CACI CACI International	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$423.75 +2.1%	$400.00 ➝ $435.00	Buy ➝ Buy
CALB California BanCorp	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.01 +1.1%	$23.50 ➝ $23.00	Outperform ➝ Outperform
CALB California BanCorp	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.01 +1.1%	$27.00 ➝ $26.00	Overweight ➝ Overweight
CARS Cars.com	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.38 +1.7%	$25.00 ➝ $25.00	Outperform ➝ Outperform
CART Maplebear	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.53 -0.5%	$28.00 ➝ $40.00	Equal Weight ➝ Equal Weight
CCRN Cross Country Healthcare	Target Lowered by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.02 -3.9%	$24.00 ➝ $21.00	Outperform ➝ Outperform
CF CF Industries	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.51 +0.6%	$100.00 ➝ $95.00	Outperform ➝ Outperform
CF CF Industries	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Isaacson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.51 +0.6%	$86.00 ➝ $80.00	Sector Perform ➝ Sector Perform
CGNX Cognex	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.49 +1.6%	$36.00 ➝ $41.00	Sell ➝ Sell
CGON CG Oncology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Maldonado Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.10 -3.2%	$75.00	Buy ➝ Buy
CHD Church & Dwight	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.41 -0.7%	$83.00 ➝ $82.00	Underweight ➝ Underweight
CHDN Churchill Downs	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.96 +1.4%	$156.00	Market Outperform ➝ Market Outperform
CLAR Clarus	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.01 -4.1%	$8.00 ➝ $9.00	Buy ➝ Buy
CLMB Climb Global Solutions	Target Lowered by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.38 -0.8%	$76.00 ➝ $68.00	Outperform ➝ Outperform
CMA Comerica	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.93 +1.6%	$60.00 ➝ $56.00	Buy ➝ Neutral
CNHI CNH Industrial	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.59 +1.0%	$18.00 ➝ $17.00	Buy ➝ Buy
CNK Cinemark	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.02 -4.0%	$24.00 ➝ $24.00	Outperform ➝ Outperform
CNMD CONMED	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$70.80 -1.3%	$107.00	Buy ➝ Buy
COHU Cohu	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.92 -2.3%	$36.00 ➝ $34.00	Buy ➝ Buy
COHU Cohu	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.92 -2.3%	$40.00 ➝ $36.00	Buy ➝ Buy
COIN Coinbase Global	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$226.93 +1.6%	$179.00 ➝ $204.00	Underweight ➝ Underweight
COST Costco Wholesale	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$756.45 +1.7%	$800.00 ➝ $800.00	Outperform ➝ Outperform
CPT Camden Property Trust	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.98 +0.9%	$99.00 ➝ $111.00	Buy ➝ Buy
CPT Camden Property Trust	Upgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.98 +0.9%	$90.00 ➝ $110.00	Underweight ➝ Neutral
CPT Camden Property Trust	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.98 +0.9%	$110.00 ➝ $118.00	Outperform ➝ Outperform
CPT Camden Property Trust	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.98 +0.9%	$107.00 ➝ $110.00	Outperform ➝ Outperform
CRBG Corebridge Financial	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.21 +1.8%	$34.00 ➝ $35.00	Overweight ➝ Overweight
CRDF Cardiff Oncology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.46 -1.7%	$14.00	Buy ➝ Buy
CRS Carpenter Technology	Reiterated by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.91 -1.7%		Buy ➝ Neutral
CRTO Criteo	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.22 -1.5%	$33.00 ➝ $40.00	Neutral ➝ Neutral
CSR Centerspace	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.35 +0.9%	$63.00 ➝ $64.00	Neutral ➝ Neutral
CTLP Cantaloupe	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.92 -0.2%	$10.00 ➝ $10.00	Outperform ➝ Outperform
CTMX CytomX Therapeutics	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.37 -1.4%	$2.50 ➝ $8.00	Hold ➝ Buy
CTO CTO Realty Growth	Target Lowered by	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.97 -0.3%	$21.00 ➝ $19.00	Buy ➝ Buy
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now
CTVA Corteva	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.36 -1.4%	$62.00 ➝ $64.00	Outperform ➝ Outperform
CTVA Corteva	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.36 -1.4%	$62.00 ➝ $65.00	Buy ➝ Buy
CVGI Commercial Vehicle Group	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.02 +0.7%	$10.00 ➝ $10.00	Outperform ➝ Outperform
D Dominion Energy	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.41 +0.0%	$51.00 ➝ $52.00	Market Perform ➝ Market Perform
DAY Dayforce	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.17 +1.5%	$82.00 ➝ $75.00	Outperform ➝ Outperform
DAY Dayforce	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.17 +1.5%	$95.00 ➝ $80.00	Buy ➝ Buy
DDOG Datadog	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.97 +2.2%	$146.00 ➝ $146.00	Buy ➝ Buy
DDOG Datadog	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.97 +2.2%	$155.00	Outperform ➝ Outperform
DECK Deckers Outdoor	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$862.68 +2.4%	$1,000.00	Outperform ➝ Outperform
DHX DHI Group	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.67 +0.4%	$7.00 ➝ $7.00	Outperform ➝ Outperform
DIS Walt Disney	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.47 +2.5%	$125.00 ➝ $130.00	Buy ➝ Buy
DIS Walt Disney	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.47 +2.5%	$113.00 ➝ $140.00	Buy ➝ Buy
DKNG DraftKings	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$53.00 ➝ $55.00	Buy ➝ Buy
DKNG DraftKings	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$51.00 ➝ $54.00	Outperform ➝ Outperform
DKNG DraftKings	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$52.00 ➝ $54.00	Overweight ➝ Overweight
DKNG DraftKings	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$34.00 ➝ $35.00	Hold ➝ Hold
DKNG DraftKings	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$50.00 ➝ $51.00	Buy ➝ Buy
DKNG DraftKings	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.07 +5.4%	$52.00 ➝ $54.00	Buy ➝ Buy
DMRC Digimarc	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.99 +0.5%		Hold
DQ Daqo New Energy	Reiterated by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.02 +0.6%	$23.50 ➝ $17.50	Hold ➝ Reduce
DRVN Driven Brands	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.00 +3.5%	$25.00 ➝ $22.00	Overweight ➝ Overweight
DSGR Distribution Solutions Group	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.48 0.0%	$42.00	Overweight ➝ Overweight
DV DoubleVerify	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.02 +2.1%	$45.00 ➝ $39.00	Overweight ➝ Overweight
DVA DaVita	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$136.87 +1.8%	$133.00 ➝ $150.00	Equal Weight ➝ Equal Weight
DYN Dyne Therapeutics	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.25 +0.7%	$47.00 ➝ $47.00	Outperform ➝ Outperform
DYN Dyne Therapeutics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.25 +0.7%	$31.00 ➝ $31.00	Buy ➝ Buy
EBAY eBay	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.38 -0.5%	$48.00 ➝ $50.00	Hold ➝ Hold
ECPG Encore Capital Group	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.32 +1.2%	$60.00	Market Outperform ➝ Market Outperform
EGP EastGroup Properties	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$158.59 -0.8%	$190.00 ➝ $172.00	Sector Perform ➝ Sector Perform
EH EHang	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.70 +7.6%	$27.50	Overweight
EMN Eastman Chemical	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.75 +1.3%	$85.00 ➝ $103.00	Equal Weight ➝ Equal Weight
ENSG The Ensign Group	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.05 -0.7%	$130.00 ➝ $135.00	Outperform ➝ Outperform
EPR EPR Properties	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.68 -0.8%		Market Perform
ESNT Essent Group	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$55.78 +2.3%	$64.00 ➝ $61.00	Outperform ➝ Outperform
ESS Essex Property Trust	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$255.63 +2.1%	$240.00 ➝ $264.00	Neutral ➝ Neutral
ESS Essex Property Trust	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$255.63 +2.1%	$291.00 ➝ $315.00	Overweight ➝ Overweight
ETON Eton Pharmaceuticals	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.75 +1.1%	$8.00	Buy
EU enCore Energy	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.89 +1.5%	$7.50	Buy
EXPE Expedia Group	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.02 +0.6%	$145.00 ➝ $125.00	Neutral ➝ Neutral
EXPE Expedia Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.02 +0.6%	$158.00 ➝ $138.00	Equal Weight ➝ Equal Weight
FANG Diamondback Energy	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$204.19 +1.3%	$195.00 ➝ $220.00	Outperform ➝ Outperform
FATE Fate Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.22 +3.9%	$7.00	Neutral ➝ Neutral
FBMS First Bancshares	Target Lowered by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.10 +1.3%	$29.50 ➝ $28.00	Market Perform
FL Foot Locker	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.28 +6.7%	$26.00 ➝ $20.00	Equal Weight ➝ Equal Weight
FLR Fluor	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.04 +0.4%	$42.00 ➝ $46.00	Outperform ➝ Outperform
FLR Fluor	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.04 +0.4%	$46.00 ➝ $47.00	Buy ➝ Buy
FLUT Flutter Entertainment	Initiated by	Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$202.76 +3.2%	$240.00	Buy
FLYW Flywire	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.01 +1.0%	$35.00 ➝ $30.00	Overweight ➝ Overweight
FNV Franco-Nevada	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.19 +2.4%	$175.00 ➝ $185.00	Buy ➝ Buy
FOXF Fox Factory	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.31 +1.8%	$55.00 ➝ $48.00	Neutral ➝ Neutral
RSVP: Charles Payne’s Cash Flow Workshop (Ad) Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies. Register For Free Now!
FTDR Frontdoor	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.95 +3.8%	$36.00 ➝ $39.00	Equal Weight ➝ Equal Weight
FTI TechnipFMC	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.35 +1.5%	$30.00 ➝ $34.00	Overweight ➝ Overweight
FTNT Fortinet	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.81 -0.1%	$80.00 ➝ $65.00	Neutral ➝ Neutral
FUBO fuboTV	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.41 +2.9%	$3.00	Buy ➝ Buy
FYBR Frontier Communications Parent	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.29 +2.6%	$41.00 ➝ $39.00	Buy ➝ Buy
GETY Getty Images	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.03 +1.5%	$7.70	Outperform
GFL GFL Environmental	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.86 +0.2%	$42.00 ➝ $43.00	Buy ➝ Buy
GHRS GH Research	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.69 +0.1%	$30.00 ➝ $31.00	Buy ➝ Buy
GKOS Glaukos	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$104.95 -1.5%	$84.00 ➝ $125.00	Hold ➝ Buy
GLYC GlycoMimetics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.32 -82.7%		Buy ➝ Neutral
GOSS Gossamer Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.78 +5.4%	$10.00	Buy ➝ Buy
GPRE Green Plains	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.90 -1.3%	$37.00 ➝ $34.00	Buy ➝ Buy
GPRE Green Plains	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.90 -1.3%	$25.00 ➝ $22.00	Market Perform ➝ Market Perform
GPRE Green Plains	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.90 -1.3%	$55.00 ➝ $40.00	Buy ➝ Buy
GPS GAP	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.20 +2.8%	$19.00 ➝ $20.00	Equal Weight ➝ Equal Weight
GRAB Grab	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.53	$6.00	Buy ➝ Buy
GTLS Chart Industries	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$157.91 +1.9%	$224.00 ➝ $220.00	Buy ➝ Buy
GTLS Chart Industries	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$157.91 +1.9%	$260.00 ➝ $265.00	Buy ➝ Buy
GTLS Chart Industries	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$157.91 +1.9%	$151.00 ➝ $160.00	Neutral ➝ Neutral
HEI HEICO	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$212.67 +0.6%	$215.00 ➝ $230.00	Buy ➝ Buy
HIW Highwoods Properties	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.27 +1.9%	$28.00 ➝ $31.00	Buy ➝ Buy
HOOD Robinhood Markets	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.78 -0.9%	$20.00 ➝ $21.00	Buy ➝ Buy
HOOD Robinhood Markets	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.78 -0.9%		Hold
HOWL Werewolf Therapeutics	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.98 -1.5%	$12.00	Market Outperform ➝ Market Outperform
HOWL Werewolf Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.98 -1.5%	$15.00	Buy ➝ Buy
HOWL Werewolf Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.98 -1.5%	$9.00	Outperform
HP Helmerich & Payne	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.45 -0.1%	$44.00 ➝ $39.00	Neutral ➝ Neutral
HSY Hershey	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$196.49 -0.7%	$200.00 ➝ $205.00	Equal Weight ➝ Equal Weight
HURN Huron Consulting Group	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.93 +0.7%	$133.00 ➝ $133.00	Outperform ➝ Outperform
HWC Hancock Whitney	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.59 +2.1%	$50.00 ➝ $55.00	Buy ➝ Buy
HWM Howmet Aerospace	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.18 +1.6%	$65.00 ➝ $85.00	Overweight ➝ Overweight
HWM Howmet Aerospace	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.18 +1.6%	$75.00 ➝ $90.00	Buy ➝ Buy
HWM Howmet Aerospace	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.18 +1.6%	$72.00 ➝ $88.00	Overweight ➝ Overweight
ILMN Illumina	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$118.98 +0.9%	$185.00 ➝ $176.00	Sector Outperform ➝ Sector Outperform
IR Ingersoll Rand	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.45 +2.0%	$105.00 ➝ $98.00	Overweight ➝ Overweight
IR Ingersoll Rand	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.45 +2.0%	$105.00 ➝ $104.00	Overweight ➝ Overweight
IR Ingersoll Rand	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.45 +2.0%	$107.00 ➝ $109.00	Outperform ➝ Outperform
IREN Iris Energy	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.30 +12.1%	$9.00 ➝ $9.00	Buy ➝ Buy
ITRI Itron	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.37 +0.3%	$85.00 ➝ $110.00	Equal Weight ➝ Equal Weight
JBLU JetBlue Airways	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.93 +2.2%	$6.00 ➝ $5.00	Underweight ➝ Underweight
JCI Johnson Controls International	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.40 +1.6%	$74.00 ➝ $68.00	Buy ➝ Neutral
JNJ Johnson & Johnson	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$148.58 -0.5%	$215.00	Overweight ➝ Overweight
JSPR Jasper Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.44 -8.5%	$65.00	Buy
JYNT Joint	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.79 -2.0%	$12.00 ➝ $20.00	Buy ➝ Buy
K Kellanova	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$60.04 -0.8%	$60.00 ➝ $64.00	Equal Weight ➝ Equal Weight
KRYS Krystal Biotech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$156.94 -2.6%	$200.00	Buy ➝ Buy
KURA Kura Oncology	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.01 +1.8%	$32.00	Market Outperform ➝ Market Outperform
LDOS Leidos	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.62 +0.7%	$145.00 ➝ $160.00	Overweight ➝ Overweight
LIN Linde	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$426.62 +0.7%	$458.00 ➝ $452.00	Buy ➝ Buy
LIN Linde	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$426.62 +0.7%	$510.00 ➝ $475.00	Outperform ➝ Outperform
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now
LINC Lincoln Educational Services	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.23 +10.3%	$13.00 ➝ $14.00	Outperform ➝ Outperform
LNC Lincoln National	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.97 +3.1%	$32.00 ➝ $30.00	Neutral ➝ Neutral
LNG Cheniere Energy	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$156.81 -0.5%	$204.00 ➝ $208.00	Buy ➝ Buy
LNT Alliant Energy	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.50 -0.7%	$55.00 ➝ $56.00	Overweight ➝ Overweight
LQDT Liquidity Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.94 -0.1%	$27.00 ➝ $27.00	Outperform ➝ Outperform
LTH Life Time Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.78 +4.5%	$23.00 ➝ $29.00	Buy ➝ Buy
LUNA Luna Innovations	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.86 -6.5%	$8.00	Buy ➝ Buy
LUV Southwest Airlines	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.42 +4.9%	$27.00 ➝ $26.00	Market Perform ➝ Market Perform
LUXH LuxUrban Hotels	Downgraded by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.83 -1.2%		Outperform ➝ Market Perform
LYB LyondellBasell Industries	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.74 +0.6%	$100.00 ➝ $104.00	Equal Weight ➝ Equal Weight
LYFT Lyft	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.52 +1.9%	$12.00 ➝ $13.00	Equal Weight ➝ Equal Weight
LYRA Lyra Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.52 -87.1%		Buy ➝ Neutral
LYRA Lyra Therapeutics	Downgraded by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.52 -87.1%		Outperform ➝ Market Perform
LYV Live Nation Entertainment	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$95.89 +1.3%	$120.00 ➝ $121.00	Buy ➝ Buy
MA Mastercard	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$449.37 +1.3%	$549.00 ➝ $530.00	Overweight ➝ Overweight
MAA Mid-America Apartment Communities	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$136.88 +2.9%	$135.00 ➝ $154.00	Neutral ➝ Outperform
MCS Marcus	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.27 -5.4%	$20.00 ➝ $20.00	Outperform ➝ Outperform
MET MetLife	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.19 +1.0%	$85.00 ➝ $82.00	Overweight ➝ Overweight
MGA Magna International	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$56.00 ➝ $48.00	Neutral ➝ Neutral
MGA Magna International	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$52.00 ➝ $49.00	Equal Weight ➝ Equal Weight
MGA Magna International	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$59.00 ➝ $54.00	Neutral
MGA Magna International	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$59.00 ➝ $55.00	Sector Perform
MGA Magna International	Target Lowered by	Evercore Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$62.00 ➝ $60.00	In-Line
MGA Magna International	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$60.00 ➝ $57.00	Market Perform
MGA Magna International	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$63.00 ➝ $62.00	Buy
MGA Magna International	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$62.00 ➝ $60.00	Equal Weight ➝ Equal Weight
MGA Magna International	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.57 -0.3%	$60.00 ➝ $57.00	Market Perform ➝ Market Perform
MGM MGM Resorts International	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.01 -0.1%	$57.00 ➝ $58.00	Market Outperform ➝ Market Outperform
MLCO Melco Resorts & Entertainment	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.37 +1.8%	$8.30 ➝ $9.60	Equal Weight ➝ Overweight
MODN Model N	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.69 -0.4%		Market Perform
MODV ModivCare	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.79 -0.8%	$50.00	Hold ➝ Buy
MOS Mosaic	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.04 +1.3%	$35.00 ➝ $32.00	Sector Perform ➝ Sector Perform
MOS Mosaic	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Isaacson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.04 +1.3%	$40.00 ➝ $38.00	Sector Outperform ➝ Sector Outperform
MPC Marathon Petroleum	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.78 +0.1%	$221.00 ➝ $195.00	Overweight ➝ Overweight
MRO Marathon Oil	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.71 +1.4%	$36.00 ➝ $35.00	Buy ➝ Buy
MSI Motorola Solutions	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$349.64 -1.1%	$355.00 ➝ $375.00	Buy ➝ Buy
MTCH Match Group	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.24 +1.0%	$50.00 ➝ $46.00	Overweight ➝ Overweight
MTSI MACOM Technology Solutions	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$103.51 +0.6%	$95.00 ➝ $115.00	Buy ➝ Buy
MTZ MasTec	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$106.00 ➝ $130.00	Overweight ➝ Overweight
MTZ MasTec	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$100.00 ➝ $120.00	Buy ➝ Buy
MTZ MasTec	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$96.00 ➝ $125.00	Buy ➝ Buy
MTZ MasTec	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$104.00 ➝ $120.00	Buy ➝ Buy
MTZ MasTec	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$96.00 ➝ $109.00	Hold ➝ Hold
MTZ MasTec	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$104.00 ➝ $113.00	Overweight ➝ Overweight
MTZ MasTec	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$89.00 ➝ $110.00	Neutral ➝ Neutral
MTZ MasTec	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.86 +4.0%	$105.00 ➝ $110.00	Buy ➝ Buy
MU Micron Technology	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.13 +4.7%	$115.00 ➝ $150.00	Neutral ➝ Outperform
NET Cloudflare	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.29 -0.1%	$115.00 ➝ $80.00	Neutral ➝ Neutral
NET Cloudflare	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.29 -0.1%	$89.00 ➝ $77.00	Sell ➝ Sell
NFE New Fortress Energy	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.17 -1.8%	$32.00 ➝ $27.00	Equal Weight ➝ Equal Weight
NR Newpark Resources	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.16 +0.8%	$12.00	Buy ➝ Buy
NR Newpark Resources	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.16 +0.8%	$10.00 ➝ $11.00	Buy ➝ Buy
NREF NexPoint Real Estate Finance	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.24 +0.2%	$16.00 ➝ $14.00	Neutral ➝ Neutral
NVT nVent Electric	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.41 +0.7%	$77.00 ➝ $87.00	Buy ➝ Buy
NVT nVent Electric	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.41 +0.7%	$91.00 ➝ $92.00	Buy ➝ Buy
NVT nVent Electric	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.41 +0.7%	$89.00 ➝ $88.00	Outperform ➝ Outperform
OHI Omega Healthcare Investors	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.14 -0.6%		Market Perform
OI O-I Glass	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.36 +1.4%	$18.00 ➝ $15.00	Equal Weight ➝ Equal Weight
OIS Oil States International	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.40 +1.9%	$8.00 ➝ $7.50	Neutral ➝ Neutral
OLLI Ollie's Bargain Outlet	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.68 +2.4%	$92.00	Buy
OMI Owens & Minor	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.21 +5.5%	$28.00 ➝ $24.00	Neutral ➝ Neutral
ONON ON	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.05 +2.3%	$32.00 ➝ $35.00	Overweight ➝ Overweight
OPI Office Properties Income Trust	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.76 -3.8%	$10.00 ➝ $7.00	Buy ➝ Buy
PAA Plains All American Pipeline	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.61 +0.7%	$17.50 ➝ $18.00	Neutral ➝ Neutral
PAA Plains All American Pipeline	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.61 +0.7%	$17.00 ➝ $18.00	Hold
PACS PACS Group	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$30.00	Outperform
PACS PACS Group	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$32.00	Buy
PACS PACS Group	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$31.00	Outperform
PACS PACS Group	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$32.00	Buy
PACS PACS Group	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$27.00	Overweight
PACS PACS Group	Initiated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.93 +0.5%	$31.00	Overweight
PAGP Plains GP	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.37 -0.2%	$17.50 ➝ $18.00	Neutral ➝ Neutral
PATK Patrick Industries	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.18 +1.8%	$120.00 ➝ $126.00	Buy ➝ Buy
PAYC Paycom Software	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$174.44 +1.8%	$185.00 ➝ $170.00	Neutral ➝ Neutral
PAYS Paysign	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.59 -3.0%	$5.50 ➝ $5.50	Outperform ➝ Outperform
PDS Precision Drilling	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.35 +1.7%	$81.00 ➝ $101.00	Overweight ➝ Overweight
PFIS Peoples Financial Services	Target Lowered by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.31 -0.7%	$48.00 ➝ $43.00	Market Perform
PH Parker-Hannifin	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$550.79 +2.7%	$640.00 ➝ $630.00	Overweight ➝ Overweight
PH Parker-Hannifin	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$550.79 +2.7%	$550.00 ➝ $590.00	Buy ➝ Buy
PINS Pinterest	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.38 +2.4%	$43.00 ➝ $49.00	Buy ➝ Buy
PLD Prologis	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$104.70 -1.1%	$145.00 ➝ $124.00	Outperform ➝ Outperform
PLMR Palomar	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.39 +3.2%	$89.00 ➝ $90.00	Overweight ➝ Overweight
PLMR Palomar	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.39 +3.2%	$88.00 ➝ $97.00	Buy ➝ Buy
PLTR Palantir Technologies	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.22 +8.1%	$35.00	Outperform ➝ Outperform
POST Post	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.40 +2.7%	$118.00 ➝ $122.00	Outperform ➝ Outperform
POST Post	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.40 +2.7%	$115.00 ➝ $120.00	Buy ➝ Buy
PRCT PROCEPT BioRobotics	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.43 -4.5%	$67.00 ➝ $75.00	Overweight ➝ Overweight
PRCT PROCEPT BioRobotics	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.43 -4.5%	$65.00 ➝ $75.00	Buy ➝ Buy
PRFT Perficient	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.26 +52.3%		Buy ➝ Hold
PRFT Perficient	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.26 +52.3%		Outperform ➝ Market Perform
PRFT Perficient	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.26 +52.3%	$50.00 ➝ $76.00	Sector Perform ➝ Sector Perform
PRLB Proto Labs	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.38 +0.9%	$38.00 ➝ $34.00	Hold ➝ Hold
PRLB Proto Labs	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.38 +0.9%		Hold
PRU Prudential Financial	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$115.26 +2.7%	$125.00 ➝ $121.00	Neutral ➝ Neutral
PTEN Patterson-UTI Energy	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.97 +2.7%		Hold
PTEN Patterson-UTI Energy	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.97 +2.7%	$17.00 ➝ $14.00	Overweight ➝ Overweight
PTON Peloton Interactive	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.54 +3.5%	$8.00 ➝ $4.00	Buy ➝ Neutral
PUMP ProPetro	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.60 +3.3%	$12.00 ➝ $13.00	Overweight ➝ Overweight
PWR Quanta Services	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$269.44 +5.1%	$301.00 ➝ $305.00	Buy ➝ Buy
RARE Ultragenyx Pharmaceutical	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.01 +0.6%	$111.00 ➝ $109.00	Buy ➝ Buy
REPX Riley Exploration Permian	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.71 +3.1%	$51.00 ➝ $48.00	Buy ➝ Buy
RGLS Regulus Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.43 -8.3%	$9.00	Buy ➝ Buy
RLAY Relay Therapeutics	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.06 +0.3%	$24.00	Market Outperform ➝ Market Outperform
RLAY Relay Therapeutics	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.06 +0.3%	$33.00 ➝ $25.00	Outperform ➝ Outperform
RMAX RE/MAX	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.66 -0.6%	$10.00 ➝ $9.00	Equal Weight ➝ Equal Weight
ROST Ross Stores	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.48 +1.3%	$161.00 ➝ $159.00	Overweight ➝ Overweight
RVLV Revolve Group	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.74 +5.4%	$17.00 ➝ $20.00	In-Line ➝ In-Line
RXO RXO	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.54 +0.6%	$22.00	Equal Weight ➝ Equal Weight
RXST RxSight	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$62.84 +1.9%	$64.00 ➝ $68.00	Buy ➝ Buy
RYAN Ryan Specialty	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.49 0.0%		Outperform ➝ Peer Perform
SAND Sandstorm Gold	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.62 +3.5%	$11.00	Buy ➝ Buy
SBUX Starbucks	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.90 -0.3%	$88.00 ➝ $85.00	Neutral ➝ Neutral
SE SEA	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$66.12 -0.8%	$78.00	Buy ➝ Buy
SEM Select Medical	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.11 +2.2%	$36.00 ➝ $40.00	Outperform ➝ Outperform
SHAK Shake Shack	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.59 -1.7%	$120.00 ➝ $125.00	Buy ➝ Buy
SHEN Shenandoah Telecommunications	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.16 +5.1%	$26.00 ➝ $26.00	Buy ➝ Buy
SIMO Silicon Motion Technology	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.58 +6.2%	$100.00 ➝ $110.00	Positive ➝ Positive
SIMO Silicon Motion Technology	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.58 +6.2%	$85.00	Buy ➝ Buy
SIMO Silicon Motion Technology	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.58 +6.2%	$59.00 ➝ $88.00	Equal Weight ➝ Overweight
SIMO Silicon Motion Technology	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.58 +6.2%	$80.00 ➝ $96.00	Buy ➝ Buy
SIMO Silicon Motion Technology	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.58 +6.2%	$101.00 ➝ $105.00	Buy ➝ Buy
SQ Block	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.56 +5.9%	$86.00 ➝ $90.00	Buy ➝ Buy
SSTK Shutterstock	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.94 +1.8%	$70.00 ➝ $65.00	Buy ➝ Buy
ST Sensata Technologies	Upgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.10 +2.6%	$44.00 ➝ $60.00	In-Line ➝ Outperform
STEM Stem	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.40 +2.2%	$2.50 ➝ $2.00	Neutral ➝ Neutral
STOK Stoke Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.87 -1.2%	$22.00	Buy ➝ Buy
SVRA Savara	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.95 +5.3%	$8.00	Market Outperform ➝ Market Outperform
SWI SolarWinds	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.80 +0.9%	$14.00 ➝ $15.00	Neutral ➝ Neutral
SWTX SpringWorks Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.32 +2.7%	$74.00	Buy ➝ Buy
SXI Standex International	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.67 -3.6%	$180.00 ➝ $180.00	Outperform ➝ Outperform
TARA Protara Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.90 -0.3%	$23.00	Buy ➝ Buy
TBLA Taboola.com	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.53 +2.3%	$6.00	Buy ➝ Buy
TLPH Talphera	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.03 +1.0%	$3.00	Buy
TNDM Tandem Diabetes Care	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.50 -2.7%	$39.00 ➝ $55.00	Overweight ➝ Overweight
TPIC TPI Composites	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.99 +6.7%	$3.30 ➝ $3.75	Neutral ➝ Neutral
TRMB Trimble	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.20 +0.5%	$73.00 ➝ $73.00	Overweight ➝ Overweight
TRMB Trimble	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.20 +0.5%	$72.00 ➝ $72.00	Outperform ➝ Outperform
TROX Tronox	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.72 -0.6%	$17.00 ➝ $22.00	Buy ➝ Buy
TS Tenaris	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.08 +0.8%	$49.00 ➝ $43.00	Overweight ➝ Overweight
TSLX Sixth Street Specialty Lending	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.04 +0.1%	$23.50 ➝ $23.00	Outperform ➝ Outperform
TSN Tyson Foods	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.50 -5.7%	$58.00 ➝ $59.00
TWST Twist Bioscience	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.67 +8.4%	$43.00 ➝ $48.00	Sector Outperform ➝ Sector Outperform
TXRH Texas Roadhouse	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$167.74 +2.5%	$155.00 ➝ $175.00	Hold ➝ Hold
UDR UDR	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.89 +1.7%	$40.00 ➝ $45.00	Outperform ➝ Outperform
UEIC Universal Electronics	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.56 +11.9%	$10.50 ➝ $11.00	Neutral ➝ Neutral
UNIT Uniti Group	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.80 -14.4%	$8.00 ➝ $6.00	Strong-Buy ➝ Outperform
URGN UroGen Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.85 -3.1%	$54.00	Buy ➝ Buy
UTZ Utz Brands	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.26 +0.1%	$20.00 ➝ $23.00	Overweight ➝ Overweight
VERU Veru	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.64 +0.6%	$2.00 ➝ $3.00	Buy ➝ Buy
VERX Vertex	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.30 +3.6%	$45.00	Buy ➝ Buy
VSCO Victoria's Secret & Co.	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.99 +2.5%	$19.00 ➝ $15.00	Equal Weight ➝ Underweight
VSTS Vestis	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.91 +5.3%	$20.00 ➝ $11.00	Neutral ➝ Neutral
VYNE VYNE Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.71 +3.4%	$5.75	Buy ➝ Buy
W Wayfair	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.49 +7.7%	$61.00 ➝ $65.00	Sector Perform ➝ Sector Perform
WCC WESCO International	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.92 +3.1%	$190.00 ➝ $200.00	Buy ➝ Buy
WEST Westrock Coffee	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.59 +0.7%	$13.00 ➝ $13.00	Outperform ➝ Outperform
WHD Cactus	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.69 +2.1%	$55.00 ➝ $56.00	Overweight ➝ Overweight
WHD Cactus	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.69 +2.1%		Hold
WKME WalkMe	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.21 +1.2%	$20.00	Buy ➝ Buy
WLDN Willdan Group	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.82 +4.9%	$35.00	Outperform ➝ Outperform
WMG Warner Music Group	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.45 +3.8%	$43.00	Overweight
WRK WestRock	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.40 +0.5%	$50.00 ➝ $57.00	Buy ➝ Buy
WSC WillScot Mobile Mini	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.30 +2.5%	$60.00 ➝ $53.00	Outperform ➝ Outperform
WTRG Essential Utilities	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.30 +1.4%	$44.00 ➝ $43.00	Outperform ➝ Outperform
WTW Willis Towers Watson Public	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$253.07 +0.4%	$317.00 ➝ $311.00	Outperform ➝ Outperform
WWD Woodward	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$173.15 +2.6%	$140.00 ➝ $175.00	Equal Weight ➝ Equal Weight
X United States Steel	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.04 +4.3%	$51.00 ➝ $48.00	Equal Weight ➝ Overweight
XPO XPO	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$110.70 -1.7%	$136.00 ➝ $138.00	Buy ➝ Buy
XPO XPO	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$110.70 -1.7%	$150.00	Overweight ➝ Overweight
XRAY DENTSPLY SIRONA	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.25 -0.1%	$34.00 ➝ $30.00	Neutral ➝ Neutral
ZTS Zoetis	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$165.95 -0.7%	$223.00 ➝ $196.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:28 PM ET.

(Ad)

The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Recent analyst ratings Headlines

Coca-Cola Stock Analysis: Key Insights and Trends
May 6, 2024 7:41 AM
View Coca-Cola Stock Analysis: Key Insights and Trends
3 Stocks Getting Boosted by Analysts
May 6, 2024 6:05 AM
View 3 Stocks Getting Boosted by Analysts
Goldman Boosted FMC Stock’s Price Targets, Setting Up a Breakout
May 1, 2024 7:38 AM
View Goldman Boosted FMC Stock’s Price Targets, Setting Up a Breakout
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
April 30, 2024 9:25 AM
View CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
Microsoft Fires a Trend Following Signal: Targets Move Higher
April 26, 2024 8:40 AM
View Microsoft Fires a Trend Following Signal: Targets Move Higher
High-Yield Texas Instruments Could Hit New Highs Soon
April 24, 2024 11:27 AM
View High-Yield Texas Instruments Could Hit New Highs Soon
GE Aerospace is Ready for Liftoff After Strong Earnings
April 24, 2024 9:07 AM
View GE Aerospace is Ready for Liftoff After Strong Earnings

More analyst ratings Headlines

Top Headlines and Offers

Seagate Technology Warns Cloud Demand is Heating Up
April 30, 2024 10:10 AM
View Seagate Technology Warns Cloud Demand is Heating Up
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
April 30, 2024 10:34 AM
View Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals(Ad)
View Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Hilton Demonstrates Asset Light is Right for Investors
April 30, 2024 11:08 AM
View Hilton Demonstrates Asset Light is Right for Investors
NXP Semiconductors Will Set a New High Soon: $300 in Sight
April 30, 2024 11:26 AM
View NXP Semiconductors Will Set a New High Soon: $300 in Sight
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
April 30, 2024 12:22 PM
View Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals(Ad)
View Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Confidence of US consumers continues to decline as Americans worry about the future
April 30, 2024 10:14 AM
View Confidence of US consumers continues to decline as Americans worry about the future
How major US stock indexes fared Tuesday, 4/30/2024
April 30, 2024 4:15 PM
View How major US stock indexes fared Tuesday, 4/30/2024
McDonald’s Trend Following Signal is an Opportunity Today
April 30, 2024 9:45 AM
View McDonald’s Trend Following Signal is an Opportunity Today
Stock market today: Asian markets follow Wall Street swings after Fed keeps interest rates high
May 1, 2024 2:31 AM
View Stock market today: Asian markets follow Wall Street swings after Fed keeps interest rates high
AMD is Down 35%. Now is the Time to Buy the Dip
May 1, 2024 10:59 AM
View AMD is Down 35%. Now is the Time to Buy the Dip

All Headlines

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial